Critical assessment of belgian reimbursement dossiers of orphan drugs.

Denis, Alain; Mergaert, Lut; Fostier, Christel; Cleemput, Irina; Hulstaert, Frank; Simoens, Steven

Denis, Alain; Mergaert, Lut; Fostier, Christel; Cleemput, Irina; Hulstaert, Frank; Simoens, Steven.

Affiliation

Denis A; Yellow Window Management Consultants, Antwerp, Belgium.

Pharmacoeconomics ; 29(10): 883-93, 2011 Oct.

Article in En | MEDLINE | ID: mdl-21905759

Subject(s)

Insurance, Health, Reimbursement/economics; Insurance, Health, Reimbursement/standards; Orphan Drug Production/economics; Belgium; Economics, Pharmaceutical; National Health Programs; Rare Diseases/drug therapy; Reimbursement Mechanisms/economics; Reimbursement Mechanisms/standards

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Orphan Drug Production / Insurance, Health, Reimbursement Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies / Qualitative_research Country/Region as subject: Europa Language: En Journal: Pharmacoeconomics Year: 2011 Type: Article Affiliation country: Belgium

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google